BioNxt Solutions Inc. (CVE:BNXT) | WebDisclosure

Basculer en Français

9815	Companies
196879	Keywords
127951	Articles
104707	Press releases

Headlines Articles Press releases BioNxt Solutions Inc.

Home
Companies
BioNxt Solutions Inc.

BRIEF

published on 08/09/2025 at 01:05, 5 months 27 days ago

BioNxt Solutions Completes Oversubscribed Convertible Debenture Offering

Private Placement Convertible Debenture Warrants Product Development BioNxt Solutions
PRESS RELEASE

published on 08/09/2025 at 01:00, 5 months 27 days ago

BioNxt Solutions Announces Closing of Final Tranche of Oversubscribed Convertible Debenture Unit Private Placement
BioNxt Solutions Inc. closes final tranche of non-brokered private placement, raising $241,200 for convertible debentures and issuing Warrants. Funds intended for product development and IP filings

Private Placement Warrants Convertible Debentures BioNxt Solutions Inc. Product Development
BRIEF

published on 08/05/2025 at 09:10, 6 months ago

BioNxt Solutions renforce la protection des brevets pour le traitement de la sclérose en plaques

Sclérose En Plaques Technologie D'administration De Médicaments Solutions BioNxt Cladribine Sublinguale Protection Par Brevet
BRIEF

published on 08/05/2025 at 09:10, 6 months ago

BioNxt Solutions Advances Patent Protection for MS Treatment

Multiple Sclerosis Drug Delivery Technology Patent Protection BioNxt Solutions Sublingual Cladribine
PRESS RELEASE

published on 08/05/2025 at 09:05, 6 months ago

BioNxt Solutions Reports Pending Patent Grants in Europe and Eurasia, Strengthening IP Protection for Proprietary Sublingual Cladribine-Based MS Treatment
BioNxt Solutions Inc. makes significant progress in global patent portfolio with EPO and EAPO confirming acceptance of core claims for sublingual Cladribine thin-film formulation. Focus on innovation in MS treatment

BioNxt Solutions Inc. Patent Portfolio Cladribine EPO EAPO
BRIEF

published on 07/26/2025 at 00:05, 6 months 10 days ago

BioNxt Solutions clôture la première tranche de son placement d'obligations

Obligations Convertibles Placement Privé Développement De Produits Mandats Solutions BioNxt
BRIEF

published on 07/26/2025 at 00:05, 6 months 10 days ago

BioNxt Solutions Closes First Tranche of Debenture Placement

Private Placement Warrants Convertible Debentures Product Development BioNxt Solutions
PRESS RELEASE

published on 07/26/2025 at 00:00, 6 months 10 days ago

BioNxt Solutions Announces Closing of First Tranche of Convertible Debenture Unit Private Placement
BioNxt Solutions Inc. closes first tranche of non-brokered private placement, raising $1,009,200 for drug delivery tech and IP development. Securities subject to statutory hold until Nov 26, 2025

Private Placement Convertible Debentures BioNxt Solutions Inc. Intellectual Property Drug Delivery Technologies
BRIEF

published on 07/23/2025 at 09:10, 6 months 13 days ago

BioNxt fait progresser le développement de couches minces de cladribine

Sclérose En Plaques Cladribine Solutions BioNxt Administration De Médicaments Film Mince Sublingual
BRIEF

published on 07/23/2025 at 09:10, 6 months 13 days ago

BioNxt Advances Cladribine Thin-Film Development

Multiple Sclerosis Cladribine Drug Delivery BioNxt Solutions Sublingual Thin-Film

Accesswire

Published on 02/05/2026 at 18:50, 54 minutes ago

Athena Gold Provides Exploration Update From Nevada and Ontario
Published on 02/05/2026 at 17:35, 2 hours 9 minutes ago

Pentagon I Capital Corp. Enters into Letter Agreement to Complete Qualifying Transaction with Prospectiva Resources Ltd.
Published on 02/05/2026 at 16:40, 3 hours 4 minutes ago

Relevant Gold Appoints Larry Taddei to Board of Directors and Mal Karwowska as Strategic Advisor
Published on 02/05/2026 at 15:45, 3 hours 59 minutes ago

American Critical Minerals Recaps a Highly Successful 6 Months and Files Amended and Restated Technical Report
Published on 02/05/2026 at 15:10, 4 hours 34 minutes ago

Electric Metals (USA) Limited Announces Change of Auditor

View all ACCESSWIRE

EQS Group

Published on 02/05/2026 at 19:27, 16 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/05/2026 at 18:46, 58 minutes ago

EQS-Adhoc: Mayr-Melnhof Karton AG: Impairment requirements impact profit for the financial year 2025
Published on 02/05/2026 at 18:09, 1 hour 35 minutes ago

Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 02/05/2026 at 17:55, 1 hour 49 minutes ago

Piramal Critical Care and Blue-Zone Technologies collaborate to capture, collect and recycle waste anaesthesia gas
Published on 02/05/2026 at 17:40, 2 hours 4 minutes ago

BROADPEAK SA: Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social au 01.02.26.

Les Echos

Published on 02/05/2026 at 19:24, 19 minutes ago

Minutes of the Combined General Meeting
Published on 02/05/2026 at 19:24, 19 minutes ago

Compte-Rendu de l’Assemblée Générale Mixte
Published on 02/05/2026 at 19:15, 29 minutes ago

ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 02/05/2026 at 19:15, 29 minutes ago

ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES JANVIER 2026
Published on 02/05/2026 at 19:15, 29 minutes ago

ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL

View all LES ECHOS COMFI WIRE